AU5340298A - Stabilized tricyclic compound - Google Patents
Stabilized tricyclic compoundInfo
- Publication number
- AU5340298A AU5340298A AU53402/98A AU5340298A AU5340298A AU 5340298 A AU5340298 A AU 5340298A AU 53402/98 A AU53402/98 A AU 53402/98A AU 5340298 A AU5340298 A AU 5340298A AU 5340298 A AU5340298 A AU 5340298A
- Authority
- AU
- Australia
- Prior art keywords
- stabilized
- tricyclic compound
- tricyclic
- compound
- stabilized tricyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34925696 | 1996-12-27 | ||
JP8-349256 | 1996-12-27 | ||
PCT/JP1997/004819 WO1998029136A1 (en) | 1996-12-27 | 1997-12-25 | Stabilized tricyclic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5340298A true AU5340298A (en) | 1998-07-31 |
Family
ID=18402542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53402/98A Withdrawn AU5340298A (en) | 1996-12-27 | 1997-12-25 | Stabilized tricyclic compound |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5340298A (en) |
WO (1) | WO1998029136A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2367402C (en) | 1999-03-12 | 2010-11-23 | Basf Aktiengesellschaft | Stable pharmaceutical dosage form for paroxetine anhydrate |
GB0804755D0 (en) | 2008-03-14 | 2008-04-16 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
WO2022089406A1 (en) * | 2020-10-26 | 2022-05-05 | 上海青煜医药科技有限公司 | Nitrogen-containing fused heterocyclic compound, and preparation method therefor and use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105791A (en) * | 1976-03-22 | 1978-08-08 | The Dow Chemical Company | Hypolipidemic cycloalkylaminobenzoic acids |
FR2569561B1 (en) * | 1984-08-30 | 1990-05-18 | Oreal | STABLE ANTHRALIN COMPOSITION IN SATURATED FATTY ACID TRIGLYCERIDES OF PLANT ORIGIN WITH 6 TO 12 CARBON ATOMS |
ATE150304T1 (en) * | 1990-09-04 | 1997-04-15 | Fujisawa Pharmaceutical Co | OINTMENTS CONTAINING TRICYCLIC COMPOUNDS |
TW438798B (en) * | 1992-10-07 | 2001-06-07 | Pfizer | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
WO1995027492A1 (en) * | 1994-04-07 | 1995-10-19 | Smithkline Beecham P.L.C. | Halofantrine free base for the treatment of malaria and compositions |
EP0771319A1 (en) * | 1994-07-15 | 1997-05-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
-
1997
- 1997-12-25 AU AU53402/98A patent/AU5340298A/en not_active Withdrawn
- 1997-12-25 WO PCT/JP1997/004819 patent/WO1998029136A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1998029136A1 (en) | 1998-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5703398A (en) | Novel compounds | |
AU3212797A (en) | Anti-viral compounds | |
AUPN842196A0 (en) | New compound | |
AU3057697A (en) | Anti-viral compounds | |
AU4925697A (en) | Compounds | |
AUPN955596A0 (en) | New compound | |
AU2752597A (en) | Anti-viral compounds | |
AU3286297A (en) | Anti-viral compounds | |
AU3620297A (en) | Substituted triazoloazinesulphonamides | |
AU5423298A (en) | Novel compounds | |
AU3212897A (en) | Anti-viral compounds | |
AU3771497A (en) | Substituted p-trifluoromethylphenyluracils | |
AUPO381496A0 (en) | New compound | |
AUPO062696A0 (en) | Novel compounds | |
AU1926397A (en) | Substituted 1-methyl-3-benzyluracils | |
AU1806397A (en) | Azo compound | |
AUPO440596A0 (en) | New compound | |
AU3711697A (en) | Novel compounds | |
AU4700497A (en) | Organic compounds | |
AU4880997A (en) | Lock | |
AU5340298A (en) | Stabilized tricyclic compound | |
AUPO371596A0 (en) | New compound | |
AU2955597A (en) | Substituted phenyluracils | |
AU1334399A (en) | Tricyclic 3-oxo-propanenitrile compounds | |
AU4641497A (en) | Novel compounds |